Skip to main content Accessibility help
  • Online publication date: March 2015

Chapter 30 - The pancreas and extrahepatic biliary system


1. Oertel JE. The pancreas. Nonneoplastic alterations. Am J Surg Pathol 1989; 13: 50–65.
2. Longnecker DS. Pathology and pathogenesis of diseases of the pancreas. Am J Pathol 1982; 107: 103–121.
3. Hruban RH, Pitman MB, Klimstra DS. Tumors of the Pancreas. Atlas of Tumor Pathology. Washington, DC: American Registry of Pathology and Armed Forces Institute of Pathology; 2007.
4. Spence JR, Wells JM. Translational embryology: using embryonic principles to generate pancreatic endocrine cells from embryonic stem cells. Dev Dyn 2007; 236(12):3218–3227.
5. Gittes GK. Developmental biology of the pancreas: a comprehensive review. Dev Biol 2009; 326(1): 4–35.
6. Ali SZ, Erozan YS, Hruban RH. Atlas of Pancreatic Cytopathology with Histopathologic Correlations. New York, NY: Demos Medical Publishing; 2009.
7. Silverman JF, Finley JL, Berns L, Unverferth M. Significance of giant cells in fine-needle aspiration biopsies of benign and malignant lesions of the pancreas. Diagn Cytopathol 1989; 5(4): 388–391.
8. Siddiqui AA, Brown LJ, Hong SK, et al. Relationship of pancreatic mass size and diagnostic yield of endoscopic ultrasound-guided fine needle aspiration. Dig Dis Sci 2011; 56(11): 3370–3375.
9. Caturelli E, Rapaccini GL, Anti M, Fabiano A, Fedeli G. Malignant seeding after fine-needle aspiration biopsy of the pancreas. Diagn Imaging Clin Med 1985; 54(2): 88–91.
10. O’Toole D, Palazzo L, Arotcarena R, et al. Assessment of complications of EUS-guided fine-needle aspiration. Gastrointest Endosc 2001; 53(4): 470–474.
11. Hara K, Yamao K, Mizuno N, et al. Interventional endoscopic ultrasonography for pancreatic cancer. World J Clin Oncol 2011; 2(2): 108–114.
12. Harris MD, Buscaglia JM. How to do pancreatic mass FNA. Gastrointest Endosc 2010; 71(4): 825–826.
13. Novis BH, Rona RU. Pure pancreatic juice cytology obtained at endoscopic retrograde cholangiopancreatography. Isr J Med Sci 1982; 18(6): 683–687.
14. Young NA, Mody DR, Davey DD. Misinterpretation of normal cellular elements in fine-needle aspiration biopsy specimens. Arch Pathol Lab Med 2002; 126(6): 670–675.
15. Centeno BA, Pitman MB. Fine Needle Aspiration Biopsy of the Pancreas. Philadelphia, PA: Butterworth Heinemann; 1999.
16. Lehman GA, Sherman S. Diagnosis and therapy of pancreas divisum. Gastrointest Endosc Clin North Am 1998; 8(1): 55–77.
17. Bertin C, Pelletier AL, Vullierme MP, et al. Pancreas divisum is not a cause of pancreatitis by itself but acts as a partner of genetic mutations. Am J Gastroent 2012; 107(2): 311–317.
18. Rusnak CH, Hosie RT, Kuechler PM, et al. Pancreatitis associated with pancreas divisum: results of surgical intervention. Am J Surg 1988; 155: 641–643.
19. Benger JR, Thompson MH. Annular pancreas and obstructive jaundice. Am J Gastroenterol 1997; 92(4): 713–714.
20. Jimenez JC, Emil S, Podnos Y, Nguyen N. Annular pancreas in children: a recent decade’s experience. J Pediatr Surg 2004; 39(11): 1654–1657.
21. Adsay NV, Hasteh F, Cheng JD, et al. Lymphoepithelial cysts of the pancreas: a report of 12 cases and a review of the literature. Mod Pathol 2002; 15(5): 492–501.
22. Mandavilli SR, Port J, Ali SZ. Lymphoepithelial cyst (LEC) of the pancreas: cytomorphology and differential diagnosis on fine-needle aspiration (FNA). Diagn Cytopathol 1999; 20(6): 371–374.
23. Centeno BA, Stockwell JW, Lewandrowski KB. Cyst fluid cytology and chemical features in a case of lymphoepithelial cyst of the pancreas: a rare and difficult preoperative diagnosis. Diagn Cytopathol 1999; 21(5): 328–330.
24. Papachristou GI, Clermont G, Sharma A, Yadav D, Whitcomb DC. Risk and markers of severe acute pancreatitis. Gastroenterol Clin North Am 2007; 36(2): 277–296.
25. Muddana V, Whitcomb DC, Papachristou GI. Current management and novel insights in acute pancreatitis. Expt Rev Gastroenterol Hepatol 2009; 3(4): 435–444.
26. Whitcomb DC. Early trypsinogen activation in acute pancreatitis. Gastroenterology 1999; 116(3): 770–772.
27. Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med 1994; 330: 1198–1210.
28. Carroll JK, Herrick B, Gipson T, Lee SP. Acute pancreatitis: diagnosis, prognosis, and treatment. Am Fam Phys 2007; 75(10): 1513–1520.
29. Uhl W, Warshaw A, Imrie C, et al. IAP guidelines for the surgical management of acute pancreatitis. Pancreatology 2002; 2(6): 565–573.
30. LaRusch J, Whitcomb DC. Genetics of pancreatitis. Curr Opin Gastroenterol 2011; 27(5): 467–474.
31. Steer ML, Waxman I, Freedman SD. Chronic pancreatitis. N Engl J Med 1995; 332: 1482–1490.
32. Jorda M, Essenfeld H, Garcia E, Ganjei P. The value of fine-needle aspiration cytology in the diagnosis of inflammatory pancreatic masses. Diagn Cytopathol 1992; 8(1): 65–67.
33. DelMaschio A, Vanzulli A, Sironi S, et al. Pancreatic cancer versus chronic pancreatitis: diagnosis with CA 19–9 assessment, US, CT, and CT-guided fine-needle biopsy. Radiology 1991; 178(1): 95–99.
34. Whitcomb DC. Mechanisms of disease: advances in understanding the mechanisms leading to chronic pancreatitis. Nat Clin Pract Gastroenterol Hepatol 2004; 1(1): 46–52.
35. Braganza JM, Lee SH, McCloy RF, McMahon MJ. Chronic pancreatitis. Lancet 2011; 377(9772): 1184–1197.
36. Cote GA, Yadav D, Slivka A, et al. Alcohol and smoking as risk factors in an epidemiology study of patients with chronic pancreatitis. Clin Gastroenterol Hepatol 2011; 9(3): 266–273.
37. Whitcomb DC. Genetic aspects of pancreatitis. Annu Rev Med 2010; 61: 413–424.
38. Hamano H, Kawa S, Horiuchi A, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344(10): 732–738.
39. Adsay NV, Basturk O, Thirabanjasak D. Diagnostic features and differential diagnosis of autoimmune pancreatitis. Semin Diagn Pathol 2005; 22(4): 309–317.
40. Klöppel G, Sipos B, Zamboni G, Kojima M, Morohoshi T. Autoimmune pancreatitis: histo- and immunopathological features. J Gastroenterol 2007; 42(Suppl 18): 28–31.
41. Hughes DB, Grobmyer SR, Brennan MF. Preventing pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis: cost effectiveness of IgG4. Pancreas 2004; 29(2): 167.
42. Zhang L, Notohara K, Levy MJ, Chari ST, Smyrk TC. IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis. Mod Pathol 2007; 20(1): 23–28.
43. Kojima M, Sipos B, Klapper W, et al. Autoimmune pancreatitis: frequency, IgG4 expression, and clonality of T and B cells. Am J SurgPathol 2007; 31(4): 521–528.
44. Mizuno N, Bhatia V, Hosoda W, et al. Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNA. J Gastroenterol 2009; 44(7): 742–750.
45. Jarboe EA, Layfield LJ. Cytologic features of pancreatic intraepithelial neoplasia and pancreatitis: potential pitfalls in the diagnosis of pancreatic ductal carcinoma. Diagn Cytopathol 2011; 39(8): 575–581.
46. Klöppel G. Pseudocysts and other non-neoplastic cysts of the pancreas. Semin Diagn Pathol 2000; 17(1): 7–15.
47. Neff R. Pancreatic pseudocysts and fluid collections: percutaneous approaches. Surg Clin North Am 2001; 81(2): 399–403, xii.
48. Nguyen GK, Suen KC, Villanueva RR. Needle aspiration cytology of pancreatic cystic lesions. Diagn Cytopathol 1997; 17(3): 177–182.
49. Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin 2011; 61(2): 69–90.
50. Lowenfels AB, Maisonneuve P. Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 2006; 20(2): 197–209.
51. Fuchs CS, Colditz GA, Stampfer MJ, et al. A prospective study of cigarette smoking and the risk of pancreatic cancer. Arch Intern Med 1996; 156(19): 2255–2260.
52. Westra WH, Hruban RH, Phelps TH, Isacson C, eds. Surgical Pathology Dissection: An Illustrated Guide. New York, NY: Springer; 2003.
53. Albores-Saavedra J, Heffess CS, Hruban RH, Klimstra DS, Longnecker DS. Recommendations for the reporting of pancreatic specimens containing malignant tumors. The Association of Directors of Anatomic and Surgical Pathology. Am J Clin Pathol 1999; 111(3): 304–307.
54. Gill AJ, Johns AL, Eckstein R, et al. Synoptic reporting improves histopathological assessment of pancreatic resection specimens. Pathology 2009; 41(2): 161–167.
55. Hong SM, Goggins M, Wolfgang CL, et al. Vascular invasion in infiltrating ductal adenocarcinoma of the pancreas can mimic pancreatic intraepithelial neoplasia: a histopathologic study of 209 cases. Am J Surg Pathol 2012; 36(2): 235–241.
56. Hyland C, Kheir SM, Kashlan MB. Frozen section diagnosis of pancreatic carcinoma: a prospective study of 64 biopsies. Am J Surg Pathol 1981; 5: 179–191.
57. Cioc AM, Ellison EC, Proca DM, Lucas JG, Frankel WL. Frozen section diagnosis of pancreatic lesions. Arch Pathol Lab Med 2002; 126(10): 1169–1173.
58. Couvelard A, Sauvanet A, Kianmanesh R, et al. Frozen sectioning of the pancreatic cut surface during resection of intraductal papillary mucinous neoplasms of the pancreas is useful and reliable: a prospective evaluation. Ann Surg 2005; 242(6): 774–778.
59. Lechago J. Frozen section examination of liver, gallbladder, and pancreas. Arch Pathol Lab Med 2005; 129(12): 1610–1618.
60. Weiland LH. Frozen section diagnosis in tumors of the pancreas. Semin Diagn Pathol 1984; 1: 54–58.
61. Robins DB, Katz RL, Evans DB, Atkinson EN, Green L. Fine needle aspiration of the pancreas. In quest of accuracy. Acta Cytol 1995; 39(1): 1–10.
62. Gold DV, Karanjawala Z, Modrak DE, Goldenberg DM, Hruban RH. PAM4-reactive MUC1 is a biomarker for early pancreatic adenocarcinoma. Clin Cancer Res 2007; 13(24): 7380–7387.
63. Nagata K, Horinouchi M, Saitou M, et al. Mucin expression profile in pancreatic cancer and the precursor lesions. J Hepato Panc Surg 2007; 14(3): 243–254.
64. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol 2002; 15(10): 1087–1095.
65. Winter JM, Ting AH, Vilardell F, et al. Absence of e-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. Clin Cancer Res 2008; 14(2): 412–418.
66. Argani P, Iacobuzio-Donahue CA, Ryu B, et al. Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res 2001; 7(12): 3862–3868.
67. Argani P, Rosty C, Reiter RE, et al. Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 2001; 61(11): 4320–4324.
68. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, et al. Molecular alterations in pancreatic carcinoma: expression profiling shows that dysregulated expression of S-100 genes is highly prevalent. J Pathol 2003; 201(1): 63–74.
69. Jones S, Zhang X, Parsons DW, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321(5897): 1801–1806.
70. Hruban RH, van Mansfeld ADM, Offerhaus GJ, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993; 143(2): 545–554.
71. Caldas C, Hahn SA, da Costa LT, et al. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nature Genet 1994; 8: 27–32.
72. Hahn SA, Schutte M, Hoque AT, et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 1996; 271: 350–353.
73. Hruban RH, Iacobuzio-Donahue CA, Wilentz RE, Goggins M, Kern SE. Molecular pathology of pancreatic cancer. Cancer J 2001; 7(4): 251–258.
74. Ryu B, Jones JB, Blades NJ, et al. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res 2002; 62(3): 819–826.
75. Schutte M, Hruban RH, Hedrick L, et al. DPC4 gene in various tumor types. Cancer Res 1996; 56: 2527–2530.
76. Wilentz RE, Su GH, Dai JL, et al. Immunohistochemical labeling for Dpc4 mirrors genetic status in pancreatic adenocarcinomas: a new marker of DPC4 inactivation. Am J Pathol 2000; 156: 37–43.
77. Tascilar M, Offerhaus GJ, Altink R, et al. Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct. Am J Clin Pathol 2001; 116(6): 831–837.
78. Hruban RH, Adsay NV, Albores-Saavedra J, et al. Pancreatic intraepithelial neoplasia: a new nomenclature and classification system for pancreatic duct lesions. Am J Surg Pathol 2001; 25(5): 579–586.
79. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61(4): 212–236.
80. Blackford A, Serrano OK, Wolfgang CL, et al. SMAD4 gene mutations are associated with poor prognosis in pancreatic cancer. Clin Cancer Res 2009; 15(14): 4674–4679.
81. Sohn TA, Yeo CJ, Lillemoe KD, et al. Resected adenocarcinoma of the pancreas – 616 patients: results, outcome, and prognostic indications. J Gastroenterol Surg 2000; 4(6): 567–579.
82. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 2004; 28(8): 977–987.
83. Matthaei H, Hong SM, Mayo SC, et al. Presence of pancreatic intraepithelial neoplasia in the pancreatic transection margin does not influence outcome in patients with R0 resected pancreatic cancer. Ann Surg Oncol 2011; 18(12): 3493–3499.
84. Bosman F, Carneiro F, Hruban RH, Theise ND, eds. WHO Classification of Tumours of the Digestive System, 4th edn. Lyon: IARC; 2010.
85. Brody JR, Costantino CL, Potoczek M, et al. Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma. Mod Pathol 2009; 22(5): 651–659.
86. Voong KR, Davison J, Pawlik TM, et al. Resected pancreatic adenosquamous carcinoma: clinicopathologic review and evaluation of adjuvant chemotherapy and radiation in 38 patients. Hum Pathol 2010; 41(1): 113–122.
87. Itani KM, Karni A, Green L. Squamous cell carcinoma of the pancreas. J Gastrointest Surg 1999; 3(5): 512–515.
88. Mockli GC, Silversmith M. Squamous cell carcinoma of the lung metastatic to the pancreas: diagnosis by fine-needle aspiration biopsy. Diagn Cytopathol 1997; 16(3): 287–288.
89. Banville N, Geraghty R, Fox E, et al. Medullary carcinoma of the pancreas in a man with hereditary nonpolyposis colorectal cancer due to a mutation of the MSH2 mismatch repair gene. Hum Pathol 2006; 37(11): 1498–1502.
90. Wilentz RE, Goggins M, Redston M, et al. Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: a newly described and characterized entity. Am J Pathol 2000; 156(5): 1641–1651.
91. Goggins M, Offerhaus GJ, Hilgers W, et al. Pancreatic adenocarcinomas with DNA replication errors (RER+) are associated with wild-type K-ras and characteristic histopathology. Poor differentiation, a syncytial growth pattern, and pushing borders suggest RER +. Am J Pathol 1998; 152: 1501–1507.
92. Yamamoto H, Itoh F, Nakamura H, et al. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability. Cancer Res 2001; 61(7): 3139–3144.
93. Adsay NV, Merati K, Nassar H, et al. Pathogenesis of colloid (pure mucinous) carcinoma of exocrine organs: coupling of gel-forming mucin (MUC2) production with altered cell polarity and abnormal cell-stroma interaction may be the key factor in the morphogenesis and indolent behavior of colloid carcinoma in the breast and pancreas. Am J Surg Pathol 2003; 27(5): 571–578.
94. Seidel G, Zahurak M, Iacobuzio-Donahue CA, et al. Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases. Am J Surg Pathol 2002; 26(1): 56–63.
95. Poultsides GA, Reddy S, Cameron JL, et al. Histopathologic basis for the favorable survival after resection of intraductal papillary mucinous neoplasm-associated invasive adenocarcinoma of the pancreas. Ann Surg 2010; 251(3): 470–476.
96. Chow LT, Chow WH. Signet-ring mucinous adenocarcinoma of the pancreas. Chin Med Sci J 1994; 9(3): 176–178.
97. Hoorens A, Prenzel K, Lemoine NR, Klöppel G. Undifferentiated carcinoma of the pancreas: anaylsis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin. J Pathol 1998; 185: 53–60.
98. Motoo Y, Kawashima A, Watanabe H, et al. Undifferentiated (anaplastic) carcinoma of the pancreas showing sarcomatous change and neoplastic cyst formation. Int J Pancreatol 1997; 21(3): 243–348.
99. Winter JM, Ting AH, Vilardell F, et al. Absence of E-cadherin expression distinguishes noncohesive from cohesive pancreatic cancer. Clin Cancer Res 2008; 14(2): 412–418.
100. Lukas Z, Dvorak K, Kroupova I, Valaskova I, Habanec B. Immunohistochemical and genetic analysis of osteoclastic giant cell tumor of the pancreas. Pancreas 2006; 32(3): 325–329.
101. Sakai Y, Kupelioglu AA, Yanagisawa A, et al. Origin of giant cells in osteoclast-like giant cell tumors of the pancreas. Hum Pathol 2000; 31(10): 1223–1229.
102. Shiozawa M, Imada T, Ishiwa N, et al. Osteoclast-like giant cell tumor of the pancreas. Int J Clin Oncol 2002; 7(6): 376–380.
103. Silverman JF, Finley JL, MacDonald KG Jr. Fine-needle aspiration cytology of osteoclastic giant-cell tumor of the pancreas. Diagn Cytopathol 1990; 6(5): 336–340.
104. Watanabe M, Miura H, Inoue H, et al. Mixed osteoclastic/pleomorphic-type giant cell tumor of the pancreas with ductal adenocarcinoma: histochemical and immunohistochemical study with review of the literature. Pancreas 1997; 15(2): 201–208.
105. Westra WH, Sturm PJ, Drillenburg P, et al. K-ras oncogene mutations in osteoclast-like giant cell tumors of the pancreas and liver: genetic evidence to support origin from the duct epithelium. Am J Surg Pathol 1998; 22(10): 1247–1254.
106. Mullick SS, Mody DR. “Osteoclastic” giant cell carcinoma of the pancreas. Report of a case with aspiration cytology. Acta Cytol 1996; 40(5): 975–979.
107. Klimstra DS, Heffess CS, Oertel JE, Rosai J. Acinar cell carcinoma of the pancreas. A clinicopathologic study of 28 cases. Am J Surg Pathol 1992; 16: 815–837.
108. Boerma D, Straatsburg IH, Offerhaus GJ, Gouma DJ, van Gulik TM. Experimental model of obstructive, chronic pancreatitis in pigs. Dig Surg 2003; 20(6): 520–526.
109. Klimstra DS, Adsay NV. Acinar cell carcinoma of the pancreas. A case associated with the lipase hypersecretion syndrome. Pathol Case Rev 2001; 6: 121–126.
110. van Klaveren RJ, de Mulder PHM, Boerbooms MT, et al. Pancreatic carcinoma with polyarthritis, fat necrosis, and high serum lipase and trypsin activity. Gut 1990; 31: 953–955.
111. Samuel LH, Frierson HF Jr. Fine needle aspiration cytology of acinar cell carcinoma of the pancreas: a report of two cases. Acta Cytol 1996; 40(3): 585–591.
112. Labate AM, Klimstra DS, Zakowski MF. Comparative cytologic features of pancreatic acinar cell carcinoma and islet cell tumor. Diagn Cytopathol 1997; 16(2): 112–116.
113. Klimstra DS, Longnecker DS. Acinar cell carcinoma. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: pp. 241–243.
114. Klimstra DS, Rosai J, Heffess CS. Mixed acinar–endocrine carcinomas of the pancreas. Am J Surg Pathol 1994; 18(8): 765–778.
115. Stelow EB, Shaco-Levy R, Klimstra DS. Pancreatic carcinomas showing acinar and ductal differentiation: mixed acinar–ductal carcinomas and mixed acinar–endocrine–ductal carcinomas. Am J Surg Pathol 2010; 34(4): 510–518.
116. Abraham SC, Wu TT, Hruban RH, et al. Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. Am J Pathol 2002; 160(3): 953–962.
117. Hoorens A, Lemoine NR, McLellan E, et al. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Pathol 1993; 143(3): 685–698.
118. Abraham SC, Klimstra DS, Wilentz RE, et al. Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations. Am J Pathol 2002; 160(4): 1361–1369.
119. Horie A. Pancreatoblastoma. Histopathologic criteria based upon a review of six cases. In: Humphrey GB, Grindey GB, Dehner LP, et al., eds. Pancreatic Tumors in Children. The Hague: Martinus Nijhoff; 1982: pp. 159–166.
120. Klimstra DS, Longnecker DS. Pancreatoblastoma. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: pp. 244–245.
121. Klimstra DS, Wenig BM, Adair CF, Heffess CS. Pancreatoblastoma. A clinicopathologic study and review of the literature. Am J Surg Pathol 1995; 19: 1371–1389.
122. Bien E, Godzinski J, Dall’igna P, et al. Pancreatoblastoma: a report from the European cooperative study group for paediatric rare tumours (EXPeRT). Eur J Cancer 2011; 47(15): 2347–2352.
123. Abraham SC, Wu TT, Klimstra DS, Finn L, Hruban RH. Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas: frequent alterations in the APC/beta-catenin pathway and chromosome 11p. Am J Pathol 2001; 159: 1619–1627.
124. Drut R, Jones MC. Congenital pancreatoblastoma in Beckwith–Wiedemann syndrome: an emerging association. PediatrPathol 1988; 8(3): 331–339.
125. Kerr NJ, Fukuzawa R, Reeve AE, Sullivan MJ, Fukazawa R. Beckwith–Wiedemann syndrome, pancreatoblastoma, and the wnt signaling pathway. Am J Pathol 2002; 160(4): 1541–1542.
126. Muguerza R, Rodriguez A, Formigo E, et al. Pancreatoblastoma associated with incomplete Beckwith–Wiedemann syndrome: case report and review of the literature. J Pediatr Surg 2005; 40(8): 1341–1344.
127. Iseki M, Suzuki T, Koizumi Y, et al. Alpha-fetoprotein-producing pancreatoblastoma. A case report. Cancer 1986; 57(9): 1833–1835.
128. Henke AC, Kelley CM, Jensen CS, Timmerman TG. Fine-needle aspiration cytology of pancreatoblastoma. Diagn Cytopathol 2001; 25(2): 118–121.
129. Silverman JF, Holbrook CT, Pories WJ, Kodroff MB, Joshi VV. Fine needle aspiration cytology of pancreatoblastoma with immunocytochemical and ultrastructural studies. Acta Cytol 1990; 34(5): 632–640.
130. Pitman MB, Faquin WC. The fine-needle aspiration biopsy cytology of pancreatoblastoma. Diagn Cytopathol 2004; 31(6): 402–406.
131. Kerr NJ, Chun YH, Yun K, et al. Pancreatoblastoma is associated with chromosome 11p loss of heterozygosity and IGF2 overexpression. Med Pediatr Oncol 2002; 39(1): 52–54.
132. Pitman MB, Lewandrowski K, Shen J, et al. Pancreatic cysts: preoperative diagnosis and clinical management. Cancer Cytopathol 2010; 118(1): 1–13.
133. Pitman MB, Genevay M, Yaeger K, et al. High-grade atypical epithelial cells in pancreatic mucinous cysts are a more accurate predictor of malignancy than “positive” cytology. Cancer Cytopathol 2010; 118(6): 434–440.
134. Genevay M, Mino-Kenudson M, Yaeger K, et al. Cytology adds value to imaging studies for risk assessment of malignancy in pancreatic mucinous cysts. Ann Surg 2011; 254(6): 977–983.
135. Carlson SK, Johnson CD, Brandt KR, Batts KP, Salomao DR. Pancreatic cystic neoplasms: the role and sensitivity of needle aspiration and biopsy. Abdom Imag 1998; 23(4): 387–393.
136. Centeno BA, Warshaw AL, Mayo-Smith W, Southern JF, Lewandrowski KB. Cytologic diagnosis of pancreatic cystic lesions. A prospective study of 28 percutaneous aspirates. Acta Cytol 1997; 41(4): 972–980.
137. Laucirica R, Schwartz MR, Ramzy I. Fine needle aspiration of pancreatic cystic epithelial neoplasms. Acta Cytol 1992; 36(6): 881–886.
138. Hara H, Suda K, Oyama T. Cytologic study of noninvasive intraductal papillary–mucinous carcinoma of the pancreas. Acta Cytol 2002; 46(3): 519–526.
139. Alles AJ, Warshaw AL, Southern JF, Compton CC, Lewandrowski KB. Expression of CA 72–4 (TAG-72) in the fluid contents of pancreatic cysts. A new marker to distinguish malignant pancreatic cystic tumors from benign neoplasms and pseudocysts. Ann Surg 1994; 219(2): 131–134.
140. Hammel P, Levy P, Voitot H, et al. Preoperative cyst fluid analysis is useful for the differential diagnosis of cystic lesions of the pancreas. Gastroenterology 1995; 108(4): 1230–1235.
141. Lewandrowski KB, Warshaw AL, Compton CC, Pins MR, Southern JF. Variability in cyst fluid carcinoembryonic antigen level, fluid viscosity, amylase content, and cytologic findings among multiple loculi of a pancreatic mucinous cystic neoplasm. Am J Clin Pathol 1993; 100(4): 425–427.
142. Hammel P, Voitot H, Vilgrain V, et al. Diagnostic value of CA 72–4 and carcinoembryonic antigen determination in the fluid of pancreatic cystic lesions. Eur J Gastroenterol Hepatol 1998; 10(4): 345–348.
143. Tatsuta M, Iishi H, Ichii M, et al. Values of carcinoembryonic antigen, elastase 1, and carbohydrate antigen determinant in aspirated pancreatic cystic fluid in the diagnosis of cysts of the pancreas. Cancer 1986; 57(9): 1836–1839.
144. Nishida K, Shiga K, Kato K, et al. Two cases of pancreatic cystadenocarcinoma with elevated CA 19–9 levels in the cystic fluid in comparison with two cases of pancreatic cystadenoma. Hepatogastroenterology 1989; 36(6): 442–445.
145. Sand JA, Hyoty MK, Mattila J, Dagorn JC, Nordback IH. Clinical assessment compared with cyst fluid analysis in the differential diagnosis of cystic lesions in the pancreas. Surgery 1996; 119(3): 275–280.
146. Khalid A, McGrath KM, Zahid M, et al. The role of pancreatic cyst fluid molecular analysis in predicting cyst pathology. Clin Gastroenterol Hepatol 2005; 3(10): 967–973.
147. Khalid A, Zahid M, Finkelstein SD, et al. Pancreatic cyst fluid DNA analysis in evaluating pancreatic cysts: a report of the PANDA study. Gastrointest Endosc 2009; 69(6): 1095–1102.
148. Wu J, Jiao Y, Dal Molin M, et al. Whole-exome sequencing of neoplastic cysts of the pancreas reveals recurrent mutations in components of ubiquitin-dependent pathways. Proc Natl Acad Sci USA 2011; 108(52): 21188–21193.
149. Wu J, Matthaei H, Maitra A, et al. Recurrent GNAS mutations define an unexpected pathway for pancreatic cyst development. Sci Transl Med 2011; 3(92): 92ra66.
150. Galanis C, Zamani A, Cameron JL, et al. Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment. J Gastrointest Surg 2007; 11: 820–826.
151. Compton CC. Serous cystic tumors of the pancreas. Semin Diagn Pathol 2000; 17(1): 43–55.
152. Bassi C, Salvia R, Molinari E, et al. Management of 100 consecutive cases of pancreatic serous cystadenoma: wait for symptoms and see at imaging or vice versa? World J Surg 2003; 27(3): 319–323.
153. Khashab MA, Shin EJ, Amateau S, et al. Tumor size and location correlate with behavior of pancreatic serous cystic neoplasms. Am J Gastroenterol 2011; 106(8): 1521–1526.
154. Mohr VH, Vortmeyer AO, Zhuang Z, et al. Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel–Lindau patients. Am J Pathol 2000; 157(5): 1615–1621.
155. Abe H, Kubota K, Mori M, et al. Serous cystadenoma of the pancreas with invasive growth: benign or malignant? Am J Gastroenterol 1998; 93(10): 1963–1966.
156. Chatelain D, Hammel P, O’Toole D, et al. Macrocystic form of serous pancreatic cystadenoma. Am J Gastroenterol 2002; 97(10): 2566–2571.
157. Egawa N, Maillet B, Schroder S, Mukai K, Klöppel G. Serous oligocystic and ill-demarcated adenoma of the pancreas: a variant of serous cystic adenoma. Virchows Arch 1994; 424(1): 13–17.
158. Fujiwara H, Ajiki T, Fukuoka K, et al. Macrocystic serous cystadenoma of the pancreas. J Hepatobil Pancreat Surg 2000; 7(1): 92–96.
159. Khadaroo R, Knetman N, Joy S, Nguyen GK. Macrocystic serous adenoma of the pancreas. Pathol Res Pract 2002; 198(7): 485–488.
160. Khurana B, Mortele KJ, Glickman J, Silverman SG, Ros PR. Macrocystic serous adenoma of the pancreas: radiologic–pathologic correlation. AJR Am J Roentgenol 2003; 181(1): 119–123.
161. Perez-Ordonez B, Naseem A, Lieberman PH, Klimstra DS. Solid serous adenoma of the pancreas. The solid variant of serous cystadenoma? Am J Surg Pathol 1996; 20(11): 1401–1405.
162. Santos LD, Chow C, Henderson CJ, et al. Serous oligocystic adenoma of the pancreas: a clinicopathological and immunohistochemical study of three cases with ultrastructural findings. Pathology 2002; 34(2): 148–156.
163. Girelli R, Bassi C, Falconi M, et al. Pancreatic cystic manifestations in von Hippel–Lindau disease. Int J Pancreatol 1997; 22(2): 101–109.
164. Mukhopadhyay B, Sahdev A, Monson JP, et al. Pancreatic lesions in von Hippel–Lindau disease. Clin Endocrinol (Oxf) 2002; 57(5): 603–608.
165. Neumann HP, Dinkel E, Brambs H, et al. Pancreatic lesions in the von Hippel–Lindau syndrome. Gastroenterology 1991; 101(2): 465–471.
166. Tseng JF, Warshaw AL, Sahani DV, et al. Serous cystadenoma of the pancreas: tumor growth rates and recommendations for treatment. Ann Surg 2005; 242(3): 413–419.
167. George DH, Murphy F, Michalski R, Ulmer BG. Serous cystadenocarcinoma of the pancreas: a new entity? Am J Surg Pathol 1989; 13: 61–66.
168. Avery AK, Beckstead J, Renshaw AA, Corless CL. Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms. Am J Surg Pathol 2000; 24(2): 203–210.
169. Wilentz RE, Albores-Saavedra J, Hruban RH. Mucinous cystic neoplasms of the pancreas. Semin Diagn Pathol 2000; 17(1): 31–42.
170. Wilentz RE, Talamini MA, Albores-Saavedra J, Hruban RH. Morphology accurately predicts behavior of mucinous cystic neoplasms of the pancreas. Mod Pathol 1999; 12(1): 169A.
171. Wilentz RE, Albores-Saavedra J, Zahurak M, et al. Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 1999; 23(11): 1320–1327.
172. Crippa S, Salvia R, Warshaw AL, et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 2008; 247(4): 571–579.
173. Fernandez-del Castillo C, Warshaw AL. Cystic neoplasms of the pancreas. Pancreatology 2001; 1(6): 641–647.
174. Goh BK, Tan YM, Chung YF, et al. A review of mucinous cystic neoplasms of the pancreas defined by ovarian-type stroma: clinicopathological features of 344 patients. World J Surg 2006; 30(12): 2236–2245.
175. Sarr MG, Carpenter HA, Prabhakar LP, et al. Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg 2000; 231(2): 205–212.
176. Zamboni G, Scarpa A, Bogina G, et al. Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors. Am J Surg Pathol 1999; 23(4): 410–422.
177. van den Berg W, Tascilar M, Offerhaus GJ, et al. Pancreatic mucinous cystic neoplasms with sarcomatous stroma: molecular evidence for monoclonal origin with subsequent divergence of the epithelial and sarcomatous components. Mod Pathol 2000; 13(1): 86–91.
178. Wenig BM, Albores-Saavedra J, Buetow PC, Heffess CS. Pancreatic mucinous cystic neoplasm with sarcomatous stroma: a report of three cases. Am J Surg Pathol 1997; 21(1): 70–80.
179. Dodd LG, Farrell TA, Layfield LJ. Mucinous cystic tumor of the pancreas: an analysis of FNA characteristics with an emphasis on the spectrum of malignancy associated features. Diagn Cytopathol 1995; 12(2): 113–119.
180. Gupta RK, alAnsari AG. Needle aspiration cytology in the diagnosis of mucinous cystadenocarcinoma of pancreas. A study of five cases with an emphasis on utility and differential diagnosis. Int J Pancreatol 1994; 15(2): 149–153.
181. Lüttges J, Feyerabend B, Buchelt T, Pacena M, Klöppel G. The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas. Am J Surg Pathol 2002; 26(4): 466–471.
182. Albores-Saavedra J, Nadji M, Henson DE, Angeles-Angeles A. Entero-endocrine cell differentiation in carcinomas of the gallbladder and mucinous cystadenocarcinomas of the pancreas. Pathol Res Pract 1988; 183(2): 169–175.
183. Ridder GJ, Maschek H, Flemming P, Nashan B, Klempnauer J. Ovarian-like stroma in an invasive mucinous cystadenocarcinoma of the pancreas positive for inhibin. A hint concerning its possible pathogenesis. Virchows Arch 1998; 432(5): 451–454.
184. Flejou JF, Boulange B, Bernades P, Belghiti J, Henin D. p53 protein expression and DNA ploidy in cystic tumors of the pancreas. Pancreas 1996; 13: 247–252.
185. Iacobuzio-Donahue CA, Wilentz RE, Argani P, et al. Dpc4 protein in mucinous cystic neoplasms of the pancreas: frequent loss of expression in invasive carcinomas suggests a role in genetic progression. Am J Surg Pathol 2000; 24(11): 1544–1548.
186. Zamboni G, Klöppel G, Hruban RH, Longnecker DS, Adler G. Mucinous cystic neoplasms of the pancreas. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: pp. 234–236.
187. Furukawa T, Klöppel G, Volkan AN, et al. Classification of types of intraductal papillary–mucinous neoplasm of the pancreas: a consensus study. Virchows Arch 2005: 447(5): 794–799.
188. Shi C, Hruban RH. Intraductal papillary mucinous neoplasm. Hum Pathol 2012; 43(1): 1–16.
189. Sohn TA, Yeo CJ, Cameron JL, et al. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience. Ann Surg 2004; 239(6): 788–797.
190. Rodriguez JR, Salvia R, Crippa S, et al. Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection. Gastroenterology 2007; 133(1): 72–79.
191. Matthaei H, Norris AL, Tsiatis AC, et al. Clinicopathological characteristics and molecular analyses of multifocal intraductal papillary mucinous neoplasms of the pancreas. Ann Surg 2012; 255: 326–333.
192. Salvia R, Fernandez-del Castillo C, Bassi C, et al. Main-duct intraductal papillary mucinous neoplasms of the pancreas: clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004; 239(5): 678–685.
193. Terris B, Ponsot P, Paye F, et al. Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct. Am J Surg Pathol 2000; 24(10): 1372–1377.
194. Adsay NV, Merati K, Basturk O, et al. Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: delineation of an “intestinal” pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004; 28(7): 839–848.
195. Sato N, Rosty C, Jansen M, et al. STK11/LKB1 Peutz–Jeghers gene inactivation in intraductal papillary–mucinous neoplasms of the pancreas. Am J Pathol 2001; 159(6): 2017–2022.
196. Z’graggen K, Rivera JA, Corris PA, et al. Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg 1997; 226: 491–498.
197. Schonleben F, Qiu W, Remotti HE, Hohenberger W, Su GH. PIK3CA, KRAS, and BRAF mutations in intraductal papillary mucinous neoplasm/carcinoma (IPMN/C) of the pancreas. Langenbecks Arch Surg 2008; 393(3): 289–296.
198. Iacobuzio-Donahue CA, Klimstra DS, Adsay NV, et al. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Am J Pathol 2000; 157(3): 755–761.
199. Furukawa T, Kuboki Y, Tanji E, et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep 2011; 1: 161.
200. Chari ST, Yadav D, Smyrk TC, et al. Study of recurrence after surgical resection of intraductal papillary mucinous neoplasm of the pancreas. Gastroenterology 2002; 123(5): 1500–1507.
201. Moriya T, Traverso W. Fate of the pancreatic remnant after resection for an intraductal papillary mucinous neoplasm: a longitudinal level II Cohort study. Arch Surg 2012; 147: 528–534.
202. Lee CJ, Scheiman J, Anderson MA, et al. Risk of malignancy in resected cystic tumors of the pancreas ≤ 3 cm in size: is it safe to observe asymptomatic patients? A multi-institutional report. J Gastrointest Surg 2008; 12(2): 234–242.
203. Levy P, Jouannaud V, O’Toole D, et al. Natural history of intraductal papillary mucinous tumors of the pancreas: actuarial risk of malignancy. Clin Gastroenterol Hepatol 2006; 4(4): 460–468.
204. Tanaka M, Chari S, Adsay NV, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006; 6(17): 32.
205. Irie H, Yoshimitsu K, Aibe H, et al. Natural history of pancreatic intraductal papillary mucinous tumor of branch duct type: follow-up study by magnetic resonance cholangiopancreatography. J Comput Assist Tomogr 2004; 28(1): 117–122.
206. Tanno S, Nakano Y, Nishikawa T, et al. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Gut 2008; 57: 339–343.
207. Adsay NV, Adair CF, Heffess CS, Klimstra DS. Intraductal oncocytic papillary neoplasms of the pancreas. Am J Surg Pathol 1996; 20(8): 980–994.
208. Jyotheeswaran S, Zotalis G, Penmetsa P, et al. A newly recognized entity: intraductal “oncocytic” papillary neoplasm of the pancreas. Am J Gastroenterol 1998; 93(12): 2539–2543.
209. Patel SA, Adams R, Goldstein M, Moskaluk CA. Genetic analysis of invasive carcinoma arising in intraductal oncocytic papillary neoplasm of the pancreas. Am J Surg Pathol 2002; 26(8): 1071–1077.
210. Liszka L, Pajak J, Zielinska-Pajak E, et al. Intraductal oncocytic papillary neoplasms of the pancreas and bile ducts: a description of five new cases and review based on a systematic survey of the literature. J Hepatobil Pancreat Sci 2010; 17(3): 246–261.
211. Klöppel G, Lüttges J, Klimstra DS, et al. Solid-pseudopapillary neoplasm. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000: pp. 246–248.
212. Reddy S, Cameron JL, Scudiere J, et al. Surgical management of solid-pseudopapillary neoplasms of the pancreas (Franz or Hamoudi tumors): a large single-institutional series. J Am Coll Surg 2009; 208(5): 950–957.
213. Kawamoto S, Scudiere J, Hruban RH, et al. Solid-pseudopapillary neoplasm of the pancreas: spectrum of findings on multidetector CT. Clin Imag 2011; 35(1): 21–28.
214. Klimstra DS, Wenig BM, Heffess CS. Solid-pseudopapillary tumor of the pancreas: a typically cystic carcinoma of low malignant potential. Semin Diagn Pathol 2000; 17(1): 66–80.
215. Notohara K, Hamazaki S, Tsukayama C, et al. Solid-pseudopapillary tumor of the pancreas: immunohistochemical localization of neuroendocrine markers and CD10. Am J Surg Pathol 2000; 24(10): 1361–1371.
216. Tanaka Y, Kato K, Notohara K, et al. Frequent beta-catenin mutation and cytoplasmic/nuclear accumulation in pancreatic solid-pseudopapillary neoplasm. Cancer Res 2001; 61(23): 8401–8404.
217. Bismar TA, Basturk O, Gerald WL, Schwarz K, Adsay NV. Desmoplastic small cell tumor in the pancreas. Am J Surg Pathol 2004; 28(6): 808–812.
218. Guo Y, Yuan F, Deng H, et al. Paranuclear dot-like immunostaining for CD99: a unique staining pattern for diagnosing solid-pseudopapillary neoplasm of the pancreas. Am J Surg Pathol 2011; 35(6): 799–806.
219. Li L, Li J, Hao C, et al. Immunohistochemical evaluation of solid pseudopapillary tumors of the pancreas: the expression pattern of CD99 is highly unique. Cancer Lett 2011; 310(1): 9–14.
220. Chetty R, Serra S. Membrane loss and aberrant nuclear localization of E-cadherin are consistent features of solid pseudopapillary tumour of the pancreas. An immunohistochemical study using two antibodies recognizing different domains of the E-cadherin molecule. Histopathology 2008; 52(3): 325–330.
221. El Bahrawy MA, Rowan A, Horncastle D, et al. E-cadherin/catenin complex status in solid pseudopapillary tumor of the pancreas. Am J Surg Pathol 2008; 32(1): 1–7.
222. Rahier J, Guiot Y, Sempoux C. Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis. Arch Dis Child Fetal Neonat Ed 2000; 82(2): F108–112.
223. Palladino AA, Stanley CA. Nesidioblastosis no longer! It’s all about genetics. J Clin Endocrinol Metab 2011; 96(3): 617–619.
224. Klöppel G, Anlauf M, Raffel A, Perren A, Knoefel WT. Adult diffuse nesidioblastosis: genetically or environmentally induced? Hum Pathol 2008; 39(1): 3–8.
225. Capelli P, Martignoni G, Pedica F, et al. Endocrine neoplasms of the pancreas: pathologic and genetic features. Arch Pathol Lab Med 2009; 133(3): 350–364.
226. Klöppel G. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms. Endocr Relat Cancer 2011; 18(Suppl 1): S1–16.
227. Adsay NV, Klimstra DS. Cystic forms of typically solid pancreatic tumors. Semin Diagn Pathol 2000; 17(1): 81–88.
228. Charfi S, Marcy M, Bories E, et al. Cystic pancreatic endocrine tumors: an endoscopic ultrasound-guided fine-needle aspiration biopsy study with histologic correlation. Cancer 2009; 117(3): 203–210.
229. Meriden Z, Shi C, Edil BH, et al. Hyaline globules in neuroendocrine and solid-pseudopapillary neoplasms of the pancreas: a clue to the diagnosis. Am J Surg Pathol 2011; 35(7): 981–988.
230. Blansfield JA, Choyke L, Morita SY, et al. Clinical, genetic and radiographic analysis of 108 patients with von Hippel–Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). Surgery 2007; 142(6): 814–818.
231. Cheng TY, Su CH, Shyr YM, Lui WY. Management of pancreatic lesions in von Hippel–Lindau disease. World J Surg 1997; 21(3): 307–312.
232. Hammel PR, Vilgrain V, Terris B, et al. Pancreatic involvement in von Hippel–Lindau disease. The Groupe Francophone d’Etude de la Maladie de von Hippel–Lindau. Gastroenterology 2000; 119(4): 1087–1095.
233. Hoang MP, Hruban RH, Albores-Saavedra J. Clear cell endocrine pancreatic tumor mimicking renal cell carcinoma: a distinctive neoplasm of von Hippel–Lindau disease. Am J Surg Pathol 2001; 25(5): 602–609.
234. Hough DM, Stephens DH, Johnson CD, Binkovitz LA. Pancreatic lesions in von Hippel–Lindau disease: prevalence, clinical significance, and CT findings. AJR Am J Roentgenol 1994; 162(5): 1091–1094.
235. Shi C, Siegelman SS, Kawamoto S, et al. Pancreatic duct stenosis secondary to small endocrine neoplasms: a manifestation of serotonin production? Radiology 2010; 257(1): 107–114.
236. Jhala D, Eloubeidi M, Chhieng DC, et al. Fine needle aspiration biopsy of the islet cell tumor of pancreas: a comparison between computerized axial tomography and endoscopic ultrasound-guided fine needle aspiration biopsy. Ann Diagn Pathol 2002; 6(2): 106–112.
237. Bell DA. Cytologic features of islet-cell tumors. Acta Cytol 1987; 31(4): 485–492.
238. Collins BT, Cramer HM. Fine-needle aspiration cytology of islet cell tumors. Diagn Cytopathol 1996; 15(1): 37–45.
239. Al-Kaisi N, Siegler EE. Fine needle aspiration cytology of the pancreas. Acta Cytol 1989; 33(2): 145–152.
240. Al-Kaisi N, Weaver MG, Abdul-Karim FW, Siegler E. Fine needle aspiration cytology of neuroendocrine tumors of the pancreas. A cytologic, immunocytochemical and electron microscopic study. Acta Cytol 1992; 36(5): 655–660.
241. Sneige N, Ordonez NG, Veanattukalathil S, Samaan NA. Fine-needle aspiration cytology in pancreatic endocrine tumors. Diagn Cytopathol 1987; 3(1): 35–40.
242. Nguyen GK, Rayani NA. Hyperplastic and neoplastic endocrine cells of the pancreas in aspiration biopsy. Diagn Cytopathol 1986; 2(3): 204–211.
243. Shaw JA, Vance RP, Geisinger KR, Marshall RB. Islet cell neoplasms. A fine-needle aspiration cytology study with immunocytochemical correlations. Am J Clin Pathol 1990; 94(2): 142–149.
244. Dodd LG, Evans DB, Symmans F, Katz RL. Fine-needle aspiration of pancreatic extramedullary plasmacytoma: possible confusion with islet cell tumor. Diagn Cytopathol 1994; 10(4): 371–374.
245. Tatsas AD, Owens CL, Siddiqui MT, Hruban RH, Ali SZ. Fine needle aspiration of intrapancreatic accessory spleen: cytomorphologic features and differential diagnosis. Cancer Cytopathol 2012; 120: 261–268.
246. Singhi AD, Hruban RH, Fabre M, et al. Peripancreatic paraganglioma: a potential diagnostic challenge in cytopathology and surgical pathology. Am J Surg Pathol 2011; 35(10): 1498–1504.
247. Strosberg JR, Cheema A, Weber J, et al. Prognostic validity of a novel American Joint Committee on Cancer Staging Classification for pancreatic neuroendocrine tumors. J Clin Oncol 2011; 29(22): 3044–3049.
248. Panzuto F, Boninsegna L, Fazio N, et al. Metastatic and locally advanced pancreatic endocrine carcinomas: analysis of factors associated with disease progression. J Clin Oncol 2011; 29(17): 2372–2377.
249. Rindi G, Klöppel G, Alhman H, et al. TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006; 449(4): 395–401.
250. Klöppel G, Rindi G, Perren A, Komminoth P, Klimstra DS. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: a statement. Virchows Arch 2010; 456(6): 595–597.
251. Tobita K, Kijima H, Chino O, et al. Pancreatic acinar cell carcinoma with endocrine differentiation: immunohistochemical and ultrastructural analyses. Anticancer Res 2001; 21(3C): 2131–2134.
252. Ohike N, Kosmahl M, Klöppel G. Mixed acinar–endocrine carcinoma of the pancreas. A clinicopathological study and comparison with acinar-cell carcinoma. Virchows Arch 2004; 445(3): 231–235.
253. Okada Y, Mori H, Tsutsumi A. Duct–acinar–islet cell tumor of the pancreas. Pathol Int 1995; 45(9): 669–676.
254. Tanakaya K, Teramoto N, Konaga E, et al. Mixed duct–acinar–islet cell tumor of the pancreas: report of a case. Surg Today 2001; 31(2): 177–179.
255. Regitnig P, Spuller E, Denk H. Insulinoma of the pancreas with insular–ductular differentiation in its liver metastasis – indication of a common stem-cell origin of the exocrine and endocrine components. Virchows Arch 2001; 438(6): 624–628.
256. Bartow SA, Mukai K, Rosai J. Pseudoneoplastic proliferation of endocrine cells in pancreatic fibrosis. Cancer 1981; 47(11): 2627–2633.
257. Hessman O, Lindberg D, Skogseid B, et al. Mutation of the multiple endocrine neoplasia type 1 gene in nonfamilial, malignant tumors of the endocrine pancreas. Cancer Res 1998; 58(3): 377–379.
258. Jiao Y, Shi C, Edil BH, et al. DAXX/ATRX, MEN1, and mTOR pathway genes are frequently altered in pancreatic neuroendocrine tumors. Science 2011; 331(6021): 1199–1203.
259. Heaphy CM, de Wilde RF, Jiao Y, et al. Altered telomeres in tumors with ATRX and DAXX mutations. Science 2011; 333(6041): 425.
260. Letizia C, Tamburrano G, Alo P, et al. Adrenomedullin, a new peptide, in patients with insulinoma. Eur J Endocrinol 2001; 144(5): 517–520.
261. Vaidakis D, Karoubalis J, Pappa T, Piaditis G, Zografos GN. Pancreatic insulinoma: current issues and trends. Hepatobil Pancreat Dis Int 2010; 9(3): 234–241.
262. Klöppel G, Anlauf M. Gastrinoma – morphological aspects. Wien Klin Wochenschr 2007; 119(19–20): 579–584.
263. Soga J, Yakuwa Y. The gastrinoma/Zollinger–Ellison syndrome: statistical evaluation of a Japanese series of 359 cases. J Hepatobiliary Pancreat Surg 1998; 5(1): 77–85.
264. Zollinger RM, Ellison EH. Primary peptic ulcerations of the jejunum associated with islet cell tumors of the pancreas. Ann Surg 1955; 142(4): 709–723.
265. Anlauf M, Perren A, Meyer CL, et al. Precursor lesions in patients with multiple endocrine neoplasia type 1-associated duodenal gastrinomas. Gastroenterology 2005; 128(5): 1187–1198.
266. Jabbour SA. Skin manifestations of hormone-secreting tumors. Dermatol Ther 2010; 23(6): 643–650.
267. Soga J, Yakuwa Y. Glucagonomas/diabetico-dermatogenic syndrome (DDS): a statistical evaluation of 407 reported cases. J Hepatobil Pancreat Surg 1998; 5(3): 312–319.
268. Chastain MA. The glucagonoma syndrome: a review of its features and discussion of new perspectives. Am J Med Sci 2001; 321(5): 306–320.
269. Chu QD, Al-kasspooles MF, Smith JL, et al. Is glucagonoma of the pancreas a curable disease? Int J Pancreatol 2001; 29(3): 155–162.
270. Soga J, Yakuwa Y. Somatostatinoma/inhibitory syndrome: a statistical evaluation of 173 reported cases as compared to other pancreatic endocrinomas. J Exp Clin Cancer Res 1999; 18(1): 13–22.
271. Nesi G, Marcucci T, Rubio CA, Brandi ML, Tonelli F. Somatostatinoma: clinico-pathological features of three cases and literature reviewed. J Gastroenterol Hepatol 2008; 23(4): 521–526.
272. Soga J, Yakuwa Y. Vipoma/diarrheogenic syndrome: a statistical evaluation of 241 reported cases. J Exp Clin Cancer Res 1998; 17(4): 389–400.
273. Almeida MQ, Stratakis CA. Solid tumors associated with multiple endocrine neoplasias. Cancer Genet Cytogenet 2010; 203(1): 30–36.
274. Anlauf M, Perren A, Klöppel G. Endocrine precursor lesions and microadenomas of the duodenum and pancreas with and without MEN1: criteria, molecular concepts and clinical significance. Pathobiology 2007; 74(5): 279–284.
275. Anlauf M, Schlenger R, Perren A, et al. Microadenomatosis of the endocrine pancreas in patients with and without the multiple endocrine neoplasia type 1 syndrome. Am J Surg Pathol 2006; 30(5): 560–574.
276. Chetty R, Clark SP, Pitson GA. Primary small cell carcinoma of the pancreas. Pathology 1993; 25(3): 240–242.
277. Reyes CV, Wang T. Undifferentiated small cell carcinoma of the pancreas: a report of five cases. Cancer 1981; 47: 2500–2502.
278. Yachida S, Vakiani E, White CM, et al. Small cell and large cell neuroendocrine carcinomas of the pancreas are genetically similar and distinct from well-differentiated pancreatic neuroendocrine tumors. Am J Surg Pathol 2012; 36(2): 173–184.
279. Shin HJ, Caraway NP. Fine-needle aspiration biopsy of metastatic small cell carcinoma from extrapulmonary sites. Diagn Cytopathol 1998; 19(3): 177–181.
280. Movahedi-Lankarani S, Hruban RH, Westra WH, Klimstra DS. Primitive neuroectodermal tumors of the pancreas: a report of seven cases of a rare neoplasm. Am J Surg Pathol 2002; 26(8): 1040–1047.
281. Gupta RK, Lallu S, Delahunt B. Fine-needle aspiration cytology of metastatic clear-cell renal carcinoma presenting as a solitary mass in the head of the pancreas. Diagn Cytopathol 1998; 19(3): 194–197.
282. Layfield LJ, Hirschowitz SL, Adler DG. Metastatic disease to the pancreas documented by endoscopic ultrasound guided fine-needle aspiration: a seven-year experience. Diagn Cytopathol 2012; 40(3): 228–233.
283. Drachenberg CB, Odorico J, Demetris AJ, et al. Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel. Am J Transpl 2008; 8(6): 1237–1249.
284. Drachenberg CB, Torrealba JR, Nankivell BJ, et al. Guidelines for the diagnosis of antibody-mediated rejection in pancreas allografts-updated Banff grading schema. Am J Transpl 2011; 11(9): 1792–1802.
285. Albores-Saavedra J, Nadji M, Morales AR, Henson DE. Carcinoembryonic antigen in normal, preneoplastic and neoplastic gallbladder epithelium. Cancer 1983; 52(6): 1069–1072.
286. Maxwell P, Davis RI, Sloan JM. Carcinoembryonic antigen (CEA) in benign and malignant epithelium of the gall bladder, extrahepatic bile ducts, and ampulla of Vater. J Pathol 1993; 170(1): 73–76.
287. Singhi AD, Adsay NV, Swierczynski SL, et al. Hyperplastic Luschka ducts: a mimic of adenocarcinoma in the gallbladder fossa. Am J Surg Pathol 2011; 35(6): 883–890.
288. Mixter CG, Mixter CG Jr. Liver nodules encountered at laparotomy: significance and treatment. Ann Surg 1953; 13S: 230–239.
289. Frey C, Bizer L, Ernst C. Agenesis of the gallbladder. Am J Surg 1967; 114(6): 917–926.
290. Raule M, Bagni CM, Marinoni M, et al. Agenesis of the gallbladder in adults: a diagnostic problem. Br J Surg 1994; 81(5): 676.
291. Kalliafas S, Ziegler DW, Flancbaum L, Choban PS. Acute acalculous cholecystitis: incidence, risk factors, diagnosis, and outcome. Am Surg 1998; 64(5): 471–475.
292. Ashur H, Siegal B, Oland Y, Adam YG. Calcified ballbladder (porcelain gallbladder). Arch Surg 1978; 113(5): 594–596.
293. Patel S, Roa JC, Tapia O, et al. Hyalinizing cholecystitis and associated carcinomas: clinicopathologic analysis of a distinctive variant of cholecystitis with porcelain-like features and accompanying diagnostically challenging carcinomas. Am J Surg Pathol 2011; 35(8): 1104–1113.
294. Towfigh S, McFadden DW, Cortina GR, et al. Porcelain gallbladder is not associated with gallbladder carcinoma. Am Surg 2001; 67(1): 7–10.
295. Dabbs DJ. Eosinophilic and lymphoeosinophilic cholecystitis. Am J Surg Pathol 1993; 17(5): 497.
296. Jessurun J, Bolio-Solis A, Manivel JC. Diffuse lymphoplasmacytic acalculous cholecystitis: a distinctive form of chronic cholecystitis associated with primary sclerosing cholangitis. Hum Pathol 1998; 29(5): 512–517.
297. Abraham SC, Cruz-Correa M, Argani P, et al. Diffuse lymphoplasmacytic chronic cholecystitis is highly specific for extrahepatic biliary tract disease but does not distinguish between primary and secondary sclerosing cholangiopathy. Am J Surg Pathol 2003; 27(10): 1313–1320.
298. LiVolsi VA, Perzin KH, Porter M. Polyarteritis nodosa of the gallbladder, presenting as acute cholecystitis. Gastroenterology 1973; 65(1): 115–123.
299. Albores-Saavedra J, Keenportz B, Bejarano PA, Alexander AA, Henson DE. Adenomyomatous hyperplasia of the gallbladder with perineural invasion: revisited. Am J Surg Pathol 2007; 31(10): 1598–1604.
300. Albores-Saavedra J, Galliani C, Chable-Montero F, Batich K, Henson DE. Mucin-containing Rokitansky–Aschoff sinuses with extracellular mucin deposits simulating mucinous carcinoma of the gallbladder. Am J Surg Pathol 2009; 33(11): 1633–1638.
301. Duarte I, Llanos O, Domke H, Harz C, Valdivieso V. Metaplasia and precursor lesions of gallbladder carcinoma. Frequency, distribution, and probability of detection in routine histologic samples. Cancer 1993; 72(6): 1878–1884.
302. Albores-Saavedra J, Henson DE, Klimstra DS. Tumors of the Gallbladder, Extrahepatic Bile Ducts, and Ampulla of Vater: Atlas of Tumor Pathology. Washington, DC: Armed Forces Institute of Pathology; 2000.
303. Wistuba II, Miquel JF, Gazdar AF, Albores-Saavedra J. Gallbladder adenomas have molecular abnormalities different from those present in gallbladder carcinomas. Hum Pathol 1999; 30(1): 21–25.
304. Chang HJ, Jee CD, Kim WH. Mutation and altered expression of beta-catenin during gallbladder carcinogenesis. Am J Surg Pathol 2002; 26(6): 758–766.
305. Yanagisawa N, Mikami T, Saegusa M, Okayasu I. More frequent beta-catenin exon 3 mutations in gallbladder adenomas than in carcinomas indicate different lineages. Cancer Res 2001; 61(1): 19–22.
306. Kozuka S, Tsubone N, Yasui A, Hachisuka K. Relation of adenoma to carcinoma in the gallbladder. Cancer 1982; 50(10): 2226–2234.
307. Wistuba II, Gazdar AF, Roa I, Albores-Saavedra J. p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 1996; 27(4): 360–365.
308. Yamagiwa H. Mucosal dysplasia of gallbladder: isolated and adjacent lesions to carcinoma. Jpn J Cancer Res 1989; 80(3): 238–243.
309. Albores-Saavedra J, Alcantra-Vazquez A, Cruz-Ortiz H, Herrera-Goepfert R. The precursor lesions of invasive gallbladder carcinoma. Hyperplasia, atypical hyperplasia and carcinoma in situ. Cancer 1980; 45(5): 919–927.
310. Albores-Saavedra J, Shukla D, Carrick K, Henson DE. In situ and invasive adenocarcinomas of the gallbladder extending into or arising from Rokitansky–Aschoff sinuses: a clinicopathologic study of 49 cases. Am J Surg Pathol 2004; 28(5): 621–628.
311. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999; 341(18): 1368–1378.
312. Hamrick RE Jr, Liner FJ, Hastings PR, Cohn I. Primary carcinoma of the gallbladder. Ann Surg 1982; 195(3): 270–273.
313. Kimura K, Ohto M, Saisho H, et al. Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. Gastroenterology 1985; 89(6): 1258–1265.
314. Yamauchi S, Koga A, Matsumoto S, Tanaka M, Nakayama F. Anomalous junction of pancreaticobiliary duct without congenital choledochal cyst: a possible risk factor for gallbladder cancer. Am J Gastroenterol 1987; 82(1): 20–24.
315. Hanada K, Itoh M, Fujii K, et al. K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer 1996; 77(3): 452–458.
316. Tokiwa K, Iwai N. Early mucosal changes of the gallbladder in patients with anomalous arrangement of the pancreaticobiliary duct. Gastroenterology 1996; 110(5): 1614–1618.
317. Rosai J. Ackerman’s Surgical Pathology. St. Louis, MO: Mosby Yearbook, Inc.; 2004.
318. Maitra A, Tascilar M, Hruban RH, Offerhaus GJA, Albores-Saavedra J. Small cell carcinoma of the gallbladder: a clinicopathologic, immunohistochemical, and molecular pathology study of 12 cases. Am J Surg Pathol 2001; 25(5): 595–601.
319. Albores-Saavedra J, Chable-Montero F, Angeles-Albores D, et al. Early gallbladder carcinoma: a clinicopathologic study of 13 cases of intramucosal carcinoma. Am J Clin Pathol 2011; 135(4): 637–642.
320. Parwani AV, Geradts J, Caspers E, et al. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Mod Pathol 2003; 16(4): 299–308.
321. Hoang MP, Murakata LA, Padilla-Rodriguez AL, Albores-Saavedra J. Metaplastic lesions of the extrahepatic bile ducts: a morphologic and immunohistochemical study. Mod Pathol 2001; 14(11): 1119–1125.
322. Zen Y, Adsay NV, Bardadin K, et al. Biliary intraepithelial neoplasia: an international interobserver agreement study and proposal for diagnostic criteria. Mod Pathol 2007; 20(6): 701–709.
323. American Joint Committee on Cancer. AJCC Cancer Staging Handbook. Edge SB, Bryd DR, Compton C, et al., eds. New York, NY: Springer; 2010.
324. Suzuki M, Takahashi T, Ouchi K, Matsuno S. The development and extension of hepatohilar bile duct carcinoma. A three-dimensional tumor mapping in the intrahepatic biliary tree visualized with the aid of a graphics computer system. Cancer 1989; 64(3): 658–666.
325. Argani P, Shaukat A, Kaushal M, et al. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts: evidence for a biologic distinction. Cancer 2001; 91(7): 1332–1341.
326. Maitra A, Krueger JE, Tascilar M, et al. Carcinoid tumors of the extrahepatic bile ducts: a study of seven cases. Am J Surg Pathol 2000; 24(11): 1501–1510.
327. Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994; 18(11): 1078–1091.
328. McCarthy DM, Hruban RH, Argani P, et al. Role of the DPC4 tumor suppressor gene in adenocarcinoma of the ampulla of Vater: analysis of 140 cases. Mod Pathol 2003; 16(3): 272–278.
329. Agaram NP, Shia J, Tang LH, Klimstra DS. DNA mismatch repair deficiency in ampullary carcinoma: a morphologic and immunohistochemical study of 54 cases. Am J Clin Pathol 2010; 133(5): 772–780.
330. Winter JM, Cameron JL, Olino K, et al. Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and long-term prognosis. J Gastrointest Surg 2010; 14(2): 379–387.
331. Nassar H, Albores-Saavedra J, Klimstra DS. High-grade neuroendocrine carcinoma of the ampulla of Vater: a clinicopathologic and immunohistochemical analysis of 14 cases. Am J Surg Pathol 2005; 29(5): 588–594.
332. Attanoos R, Williams GT. Epithelial and neuroendocrine tumors of the duodenum. Semin Diagn Pathol 1991; 8(3): 149–162.
333. Burke AP, Helwig EB. Gangliocytic paraganglioma. Am J Clin Pathol 1989; 92(1): 1–9.
334. Perrone T, Sibley RK, Rosai J. Duodenal gangliocytic paraganglioma. An immunohistochemical and ultrastructural study and a hypothesis concerning its origin. Am J Surg Pathol 1985; 9(1): 31–41.
335. Ogata S, Horio T, Sugiura Y, Aiko S, Aida S. Duodenal gangliocytic paraganglioma with regional lymph node metastasis and a glandular component. Pathol Int 2011; 61(2): 104–107.
336. Yamanaka S, Sunamura M, Furukawa T, et al. Chromosome 12, frequently deleted in human pancreatic cancer, may encode a tumor-suppressor gene that suppresses angiogenesis. Lab Invest 2004; 84(10): 1339–1351.